Navigation Links
Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
Date:5/23/2008

he disease will increase from almost 30 million in 2002 to nearly 41 million in 2020. Up to 20 percent of a woman's expected lifetime bone loss can occur in the years immediately following menopause. The treatment of postmenopausal osteoporosis could lead to significant improvement in the overall health for millions of women worldwide as well as reduce costs associated with postmenopausal osteoporosis-related fractures.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products (including that there can be no assurance that our pending new drug applications for bazedoxifene will be approved or that the product will ever be successfully commercialized); government cost-containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, includ
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
2. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
3. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
4. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
5. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
6. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
7. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
10. Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
11. Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Ill. , July 28, 2015 Today,s ... on par with their levels of clinical excellence. Today ... Annual Meeting & Clinical Lab Expo, Sysmex is announcing ... a comprehensive and intuitive ecosystem that will help laboratories ... key areas, Sysmex aims to add even more value ...
(Date:7/28/2015)... 2015 Research and Markets ... "Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019" ... therapeutics market to grow at a CAGR of 1.09% ... the present scenario and the growth prospects of the ... calculate the market size, the report considers revenue generated ...
(Date:7/28/2015)... , July 28, 2015   DigiPath Labs ... DIGP), is combining efforts with True North Laboratory of ... Romer Labs , a leading global supplier of diagnostic ... utilizing Romer Labs, rapid diagnostic test kits ... in cannabis. "This joint effort is expected ...
Breaking Medicine Technology:Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 3
... AMSTERDAM, The Netherlands, June 30 ... Major Impact on the Decision-Making Process With,Respect to Infertility ... an economic analysis presented today at this year,s,European Society ... the parameters of the simulation model used, the in ...
... ROCHESTER, Minn., June 29 Pioneering therapeutic trials to ... in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette,s ... according to a review in the June 2009 issue of ... . "Deep brain stimulation has long been seen as valuable ...
Cached Medicine Technology:New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3
(Date:7/28/2015)... , ... July 28, 2015 , ... Women fear developing ... reason is that cancer, heart attack, and stroke are treatable, but there is little ... can do is to take part in a clinical trial, reports the July 2015 ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... of Acute Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of whom ... cardiology is the identification of individuals with active yet undetected sub-clinical disease, who ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... for identifying Top Doctors, has based its selection process on the foundation of ... in their medical specialties, in any area of medicine and in any part ...
(Date:7/28/2015)... ... 2015 , ... One of the most common running related ... plantar fasciitis . Zensah, the Miami-based compression brand, offers a product that can ... the Zensah Ankle Support’s primary benefits include helping support the ankle, reduce swelling, ...
(Date:7/28/2015)... ... July 28, 2015 , ... Nurses across all settings ... up to 57 million Americans may need mental health services (SAMHSA, 2013) and the ... Psychiatric-mental health RNs are one of the largest workforces who provide care to ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 3Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 4
... A novel gene called rumi regulates Notch signaling by ... Notch protein that extends outside a cell, said researchers ... Brook University in New York in a report that ... governed by the Notch protein determines cell fate determination ...
... works for allergic asthma, rhinitis, conjunctivitis or insect ... If you have allergic asthma, rhinitis, conjunctivitis or ... candidate for allergy shots, also known as immunotherapy. ... of Allergy, Asthma & Immunology. , "Immunotherapy is ...
... MYL ),today announced that it intends to appeal ... for the District of Columbia against Mylan and its ... of the,pending Lorazepam and Clorazepate antitrust cases. The first ... disclosed, in June 2005, a jury in the district ...
... Society of Plastic Surgeons (ASPS) today addressed concerns,regarding ... events following,a recent petition from a consumer group., ... U.S. Food and Drug,Administration (FDA) implement labeling changes ... one million people have been treated with BOTOX ...
... Unland, President of the,Chicago-based Health Capital Group, urged hospitals, ... their existing debt instruments, their,obligations and their capital and ... Problems with some major banks and bond insurers have ... do so for some time to come,resulting in both ...
... no medical benefit; heart expert calls it ,second-line, ... The controversy surrounding the highly promoted cholesterol-lowering drug ... they would review the medication,s effectiveness, but only ... debate began earlier this month when preliminary results ...
Cached Medicine News:Health News:Notch-ing glucose into place 2Health News:Allergy Shots Are Effective Treatment for Symptoms 2Health News:Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2Health News:Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans 2Health News:FDA Will Wait for Trial Results on Vytorin 2Health News:FDA Will Wait for Trial Results on Vytorin 3
... advanced 16 to 64 channel sleep diagnostic ... 16 to 64 channel sleep diagnostic collection ... sleep event recording or post recording. The ... recorded during sleep events including current number ...
Aurora is a powerful Windows-based digital PSG instrument providing complete data acquisition, recording and review capabilities in one flexible package. The Aurora offers the most feature-packed PSG...
... gold-ball electrodes in a double-horn assembly ... electrode is in a ball and ... Supporting bone clamp design simplifies three ... braided, Teflon-coated wires terminate in a ...
... Medelec Synergy N-EP provides total testing ... smaller instrument is driven by space ... testing equipment on the move ... 2, 5, or 10-channel Medelec Synergy ...
Medicine Products: